Find grants for Health

Total Dollars Available
$ 100 Trillion

Add Your Heading Text Here

Showing 25 of 438 grants in "Health"

National Indian Health Outreach and Education

Deadline: November 2, 2026


Opportunity Number: HHS-2026-IHS-NIHOE-0001

Agency: Indian Health Service

Open Date: September 9, 2026

Close Date: November 2, 2026

Status: Posted

CFDA Numbers: 93.00L

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Deadline: February 5, 2027


Opportunity Number: CDC-RFA-DP-27-0023

Agency: Centers for Disease Control - NCCDPHP

Open Date: September 3, 2026

Close Date: February 5, 2027

Status: Posted

CFDA Numbers: 93.898

Improving the Capacity of Tribal Communities to Identify Emerging Drug Threats

Deadline: September 13, 2026


Opportunity Number: RD-ET-RDA-26-002

Agency: Office of National Drug Control Policy

Open Date: September 2, 2026

Close Date: September 13, 2026

Status: Posted

CFDA Numbers: 95.007

NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)

Deadline: April 17, 2029


Opportunity Number: PAR-27-051

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: April 17, 2029

Status: Posted

CFDA Numbers: 93.853, 93.279, 93.121, 93.242, 93.273, 93.399

Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)

Deadline: July 16, 2028


Opportunity Number: PAR-27-096

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: July 16, 2028

Status: Posted

CFDA Numbers: 93.361, 93.121, 93.307, 93.866

Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)

Deadline: June 12, 2028


Opportunity Number: PAR-27-112

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: June 12, 2028

Status: Posted

CFDA Numbers: 93.866

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Deadline: November 10, 2026


Opportunity Number: RFA-AI-27-005

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 93.855

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Deadline: November 10, 2026


Opportunity Number: RFA-AI-27-002

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 93.855

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Deadline: October 9, 2028


Opportunity Number: RFA-AI-27-014

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: October 9, 2028

Status: Posted

CFDA Numbers: 93.839, 93.837, 93.853, 93.840, 93.846, 93.867, 93.855, 93.233, 93.279, 93.838

Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)

Deadline: May 25, 2028


Opportunity Number: PAR-27-127

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: May 25, 2028

Status: Posted

CFDA Numbers: 93.242

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

Deadline: November 10, 2026


Opportunity Number: RFA-AG-27-010

Agency: National Institutes of Health

Open Date: September 1, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 93.866

Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)

Deadline: November 6, 2026


Opportunity Number: RFA-DK-27-125

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: November 6, 2026

Status: Posted

CFDA Numbers: 93.847

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Deadline: November 9, 2026


Opportunity Number: RFA-DK-27-112

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: November 9, 2026

Status: Posted

CFDA Numbers: 93.847

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

Deadline: March 9, 2029


Opportunity Number: PAR-27-065

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: March 9, 2029

Status: Posted

CFDA Numbers: 93.853

Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)

Deadline: September 30, 2026


Opportunity Number: RFA-DK-27-127

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: September 30, 2026

Status: Posted

CFDA Numbers: 93.847

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Deadline: October 1, 2026


Opportunity Number: RFA-CA-27-005

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: October 1, 2026

Status: Posted

CFDA Numbers: 93.394, 93.395

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Deadline: June 23, 2028


Opportunity Number: RFA-NS-27-002

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: June 23, 2028

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.853, 93.867, 93.286, 93.372, 93.866, 93.865, 93.173, 93.213, 93.273

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Deadline: January 25, 2027


Opportunity Number: PAR-28-062

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: January 25, 2027

Status: Posted

CFDA Numbers: 93.399

Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)

Deadline: October 2, 2028


Opportunity Number: PAR-27-068

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: October 2, 2028

Status: Posted

CFDA Numbers: 93.859

Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)

Deadline: July 7, 2028


Opportunity Number: PAR-27-076

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: July 7, 2028

Status: Posted

CFDA Numbers: 93.855, 93.233, 93.838, 93.840, 93.879, 93.307, 93.839, 93.273, 93.372, 93.853, 93.310, 93.113, 93.173, 93.398, 93.847, 93.865, 93.242, 93.866, 93.121, 93.213, 93.837

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

Deadline: November 9, 2026


Opportunity Number: RFA-DK-27-139

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: November 9, 2026

Status: Posted

CFDA Numbers: 93.847

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Deadline: June 16, 2028


Opportunity Number: PAR-27-053

Agency: National Institutes of Health

Open Date: August 31, 2026

Close Date: June 16, 2028

Status: Posted

CFDA Numbers: 93.279

Fiscal Year (FY) 2027 AmeriCorps State and National Competitive Grants

Deadline: January 13, 2027


Opportunity Number: AC-08-28-26

Agency: AmeriCorps

Open Date: August 28, 2026

Close Date: January 13, 2027

Status: Posted

CFDA Numbers: 94.006

Long-term health outcomes of people living with spina bifida

Deadline: October 26, 2026


Opportunity Number: CDC-RFA-DD-26-0222

Agency: Centers for Disease Control - NCBDDD

Open Date: August 26, 2026

Close Date: October 26, 2026

Status: Posted

CFDA Numbers: 93.073

Fiscal Year (FY) 2027 AmeriCorps Seniors RSVP Competition

Deadline: October 20, 2026


Opportunity Number: AC-08-20-2026

Agency: AmeriCorps

Open Date: August 20, 2026

Close Date: October 20, 2026

Status: Posted

CFDA Numbers: 94.002

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.